A global leader
in human genetics

Carrying forward more than a decade of leadership in understanding the genome


deCODE genetics (also doing business as deCODE genetics ehf, Islensk erfdagreining ehf, and deCODE genetics Ltd.) is a private company headquartered in Reykjavik, Iceland. The company is owned by Saga Investments LLC, a consortium including Polaris Venture Partners and ARCH Venture Partners. deCODE  currently has no publicly traded securities. Please note that none of the publicly owned stocks or other securities issued by deCODE's U.S-based former parent company, including its common stock that has been traded on the Pink Sheets over-the-counter market under the ticker symbol "DCGNQ", are or will become securities of deCODE genetics, which is an independent and separate company.

 

For more information on deCODE's former parent company, now known as DGI Resolution, Inc., click here.